Follow The Filings

ALMS Alumis

Alumis earnings company data as of 7:04 PM ET 11/19

  • 1 of 2 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS -0.75 -0.73 Beat
Rev $1.7M $1.9M Beat +12.9%
FY2026 Q2 13 Aug EPS -0.71 -1.11 Miss
Rev — $1.7M —

Insider trades

Open-market buys and sales by ALMS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALMS insider trades
  • $46.9M bought by 4 insiders
  • $1.2M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Srinivas Akkaraju Director
    Buy
    $10.7M 986,721 shares at $10.87 +75% to stake
    Traded Sep 4–8 Filed Sep 9
  2. Srinivas Akkaraju Director
    Sale
    $1M 96,131 shares at $10.55 4.5% of stake
    Traded Sep 8 Filed Sep 9
  3. Sanam Pangali Chief Legal Officer
    Sale
    $140K 5,000 shares at $28.00 31% of stake
    Traded Jul 6 Filed Jul 8
  4. Srinivas Akkaraju Director
    Buy
    $10M 588,235 shares at $17.00 +47% to stake
    Traded Jan 9 Filed Jan 13
  5. Foresite Labs, LLC 10% owner, +1 joint filer
    Buy
    $7M 411,764 shares at $17.00 +17% to stake
    Traded Jan 8 Filed Jan 12
  6. Srinivas Akkaraju Director
    Buy
    $1.8M 186,377 shares at $9.84 +17% to stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
  7. Srinivas Akkaraju Director
    Buy
    $2M 262,027 shares at $7.79 +32% to stake
    Traded Dec 2–4 Filed Dec 4, 2025
  8. Srinivas Akkaraju Director
    Buy
    $1.3M 173,589 shares at $7.55 +27% to stake
    Traded Nov 26, 2025–Dec 1, 2025 Filed Dec 1, 2025
  9. Foresite Capital Management VI LLC 10% owner, +8 joint filers
    Buy
    $533K 72,212 shares at $7.38 +2.8% to stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
  10. Srinivas Akkaraju Director
    Buy
    $905K 125,743 shares at $7.20 +24% to stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
  11. Srinivas Akkaraju Director
    Buy
    $1.5M 241,338 shares at $6.34 +87% to stake
    Traded Nov 17–19 Filed Nov 19, 2025

Also filed in the last 12 months, not counted as buying or selling: 12 other transactions, 12 sales to cover taxes, 5 stock grants, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 8.01,9.01
8-K 2.02,9.01
10-Q
8-K 8.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13D/A —
8-K 5.07
8-K 8.01,9.01
DEF 14A
DEFA14A
8-K 2.02,9.01
10-Q
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf